Ieq Capital LLC lowered its holdings in Tenet Healthcare Corporation (NYSE:THC – Free Report) by 16.1% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 52,131 shares of the company’s stock after selling 10,019 shares during the quarter. Ieq Capital LLC owned 0.07% of Tenet Healthcare worth $13,323,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other large investors also recently bought and sold shares of the business. Manning & Napier Advisors LLC purchased a new position in shares of Tenet Healthcare in the 2nd quarter worth $168,761,000. Aberdeen Group plc raised its position in shares of Tenet Healthcare by 4,392.9% during the 3rd quarter. Aberdeen Group plc now owns 845,555 shares of the company’s stock valued at $216,090,000 after buying an additional 826,735 shares in the last quarter. Bank of New York Mellon Corp bought a new position in shares of Tenet Healthcare in the 2nd quarter valued at about $106,342,000. Arrowstreet Capital Limited Partnership grew its position in Tenet Healthcare by 57.4% in the first quarter. Arrowstreet Capital Limited Partnership now owns 671,700 shares of the company’s stock worth $126,757,000 after acquiring an additional 244,901 shares in the last quarter. Finally, Voya Investment Management LLC grew its position in Tenet Healthcare by 346.2% in the third quarter. Voya Investment Management LLC now owns 162,756 shares of the company’s stock worth $41,594,000 after acquiring an additional 126,283 shares in the last quarter. 95.44% of the stock is currently owned by institutional investors.
Key Headlines Impacting Tenet Healthcare
Here are a few of the latest headlines about THC:
- Positive Sentiment: Zacks Research raised its EPS forecasts across several quarters and full years. Its FY2027 estimate increased to $19.77 from $18.91, and its FY2028 estimate rose to $20.98 from $20.09. Higher analyst expectations may support investor sentiment by suggesting improved earnings prospects. Tenet Healthcare analyst estimates
- Positive Sentiment: A separate Zacks article characterized THC as a top-ranked momentum stock, a potentially favorable signal for investors focused on price trends. Zacks momentum-stock article
- Neutral Sentiment: Despite the estimate increases, Zacks Research maintained a “Hold” rating, indicating it did not make a more bullish recommendation. Tenet Healthcare analyst information
Tenet Healthcare Stock Down 0.1%
NYSE THC opened at $263.34 on Friday. The business has a fifty day moving average price of $268.86 and a 200 day moving average price of $226.99. Tenet Healthcare Corporation has a one year low of $157.58 and a one year high of $301.44. The company has a debt-to-equity ratio of 1.76, a quick ratio of 1.52 and a current ratio of 1.58. The company has a market cap of $20.96 billion, a P/E ratio of 7.64, a P/E/G ratio of 1.56 and a beta of 1.20.
Tenet Healthcare (NYSE:THC – Get Free Report) last announced its earnings results on Thursday, October 29th. The company reported $6.64 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.68 by $1.96. Tenet Healthcare had a net margin of 13.09% and a return on equity of 28.22%. The company had revenue of $6.28 billion for the quarter, compared to analysts’ expectations of $5.49 billion. During the same quarter in the previous year, the company posted $3.70 EPS. The firm’s quarterly revenue was up 6.5% on a year-over-year basis. Research analysts anticipate that Tenet Healthcare Corporation will post 22.32 EPS for the current fiscal year.
Wall Street Analyst Weigh In
A number of equities research analysts have issued reports on THC shares. Royal Bank Of Canada upped their price objective on Tenet Healthcare from $283.00 to $304.00 and gave the company an “outperform” rating in a research report on Monday, November 2nd. Barclays boosted their target price on Tenet Healthcare from $271.00 to $297.00 and gave the company an “overweight” rating in a research report on Wednesday, November 4th. Deutsche Bank raised their price target on Tenet Healthcare from $260.00 to $320.00 and gave the stock a “buy” rating in a research report on Friday, October 30th. Robert W. Baird lifted their price objective on shares of Tenet Healthcare from $210.00 to $280.00 and gave the stock a “neutral” rating in a research note on Tuesday, July 28th. Finally, Truist Financial reissued a “buy” rating and issued a $305.00 target price (up from $290.00) on shares of Tenet Healthcare in a research note on Tuesday, November 3rd. Nineteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $296.65.
Get Our Latest Stock Analysis on Tenet Healthcare
Insider Transactions at Tenet Healthcare
In other news, Director Nadja West sold 1,152 shares of the firm’s stock in a transaction that occurred on Wednesday, September 2nd. The shares were sold at an average price of $258.80, for a total value of $298,137.60. Following the completion of the transaction, the director owned 23,653 shares of the company’s stock, valued at approximately $6,121,396.40. This trade represents a 4.64% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director J. Robert Kerrey sold 12,010 shares of the stock in a transaction dated Monday, September 14th. The shares were sold at an average price of $263.72, for a total value of $3,167,277.20. Following the completion of the sale, the director directly owned 4,794 shares in the company, valued at $1,264,273.68. This represents a 71.47% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last three months, insiders have sold 99,462 shares of company stock worth $27,081,234. 0.97% of the stock is owned by corporate insiders.
Tenet Healthcare Profile
Tenet Healthcare Corporation is a U.S.-based healthcare services company that operates acute care hospitals and provides related inpatient and outpatient services. Its hospitals offer services across areas such as emergency care, surgery, imaging and specialty treatment. Through its subsidiary United Surgical Partners International (USPI), Tenet also operates ambulatory surgery centers and surgical hospitals, providing outpatient surgical and procedural care. The company’s Conifer Health Solutions business provides revenue cycle management and other administrative services to healthcare providers.
See Also
- Five stocks we like better than Tenet Healthcare
- MarketBeat Week in Review – 11/16 – 11/20
- Survey Reveals: How Much Would People Pay for Ribeye Before Giving It Up? [2026]
- If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel It
- 3 Dividend ETFs Offering Steadier Footing in a Shaky Market
Want to see what other hedge funds are holding THC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tenet Healthcare Corporation (NYSE:THC – Free Report).
Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
